Difference between revisions of "Forodesine (Fodosine)"
Jump to navigation
Jump to search
m (Jwarner moved page Forodesine to Forodesine (Fodosine): Added brand name.) |
m (Text replacement - "http://www.ncbi.nlm" to "https://www.ncbi.nlm") |
||
Line 5: | Line 5: | ||
===[[T-cell lymphoma]]=== | ===[[T-cell lymphoma]]=== | ||
− | # Dummer R, Duvic M, Scarisbrick J, Olsen EA, Rozati S, Eggmann N, Goldinger SM, Hutchinson K, Geskin L, Illidge TM, Giuliano E, Elder J, Kim YH. Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome). Ann Oncol. 2014 Sep;25(9):1807-12. Epub 2014 Jun 19. [http://annonc.oxfordjournals.org/content/25/9/1807.full.html link to original article] [ | + | # Dummer R, Duvic M, Scarisbrick J, Olsen EA, Rozati S, Eggmann N, Goldinger SM, Hutchinson K, Geskin L, Illidge TM, Giuliano E, Elder J, Kim YH. Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome). Ann Oncol. 2014 Sep;25(9):1807-12. Epub 2014 Jun 19. [http://annonc.oxfordjournals.org/content/25/9/1807.full.html link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/24948692 PubMed] |
==Also known as== | ==Also known as== |
Revision as of 02:58, 2 December 2016
Mechanism of action
Purine nucleoside phosphorylase (PNP) inhibitor
Preliminary data
T-cell lymphoma
- Dummer R, Duvic M, Scarisbrick J, Olsen EA, Rozati S, Eggmann N, Goldinger SM, Hutchinson K, Geskin L, Illidge TM, Giuliano E, Elder J, Kim YH. Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome). Ann Oncol. 2014 Sep;25(9):1807-12. Epub 2014 Jun 19. link to original article PubMed
Also known as
Immucillin H